2.80
Revelation Biosciences Inc (REVB) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
|
17.48%
2.4612
|
2.095 | 1.7539 | 1.7967 | 2.5224 |
Operating Income/Loss |
17.48%
-2.4612
|
-2.095 | -1.7539 | -1.7967 | -2.5224 |
Nonoperating Income/Loss |
61.63%
0.0168
|
0.0439 | 0.0282 | -0.4449 | -5.8674 |
Income/Loss From Continuing Operations Before Tax |
19.18%
-2.4444
|
-2.0511 | -1.7257 | -2.2416 | -8.3898 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
19.18%
-2.4444
|
-2.0511 | -1.7257 | -2.2416 | -8.3898 |
|
19.18%
-2.4444
|
-2.0511 | -1.7257 | -2.2416 | -8.3898 |
Preferred Stock Dividends And Other Adjustments |
3.1818
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
17.36%
0.8027
|
0.9713 | -1.6334 | 2.6799 | 1.6352 |
Diluted Average Shares |
17.36%
0.8027
|
0.9713 | -1.6334 | 2.6799 | 1.6352 |
Basic Earnings Per Share |
232.23%
-7.01
|
-2.11 | -80.30 | -0.84 | -5.13 |
Diluted Earnings Per Share |
232.23%
-7.01
|
-2.11 | -80.30 | -0.84 | -5.13 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
3.1818
|
- | - | - | - |
자본화:
|
볼륨(24시간):